한글목차

세계 리포솜 보충제 시장은 2024년에 9억 347만 달러에 달했고, 2033년에는 1조 5,680억 달러에 이를 것으로 예측되며, 예측 기간(2025-2033년)의 CAGR은 6.3%로 성장할 것으로 예상됩니다.

리포좀은 인지질 이중층으로 구성된 작은 소포로 약물 전달의 의약품 용도에 널리 사용됩니다. 일부 보충제는 안정성을 높이고 소화관 환경으로부터 보호하며 전반적인 흡수를 향상시키기 위해 리포솜으로 캡슐화 할 수 있습니다.

천연 세포막과 유사한 리포좀은 기존의 제형에 비해 보충제를 직접 혈류에 넣고 세포 내로 흡수하는 것을 가능하게 하고, 보다 높은 생물학적 이용능력(생체이용률)을 보장합니다. 지용성 비타민, 수용성 비타민 및 미네랄의 거의 모든 것을 리포좀 담체를 사용하여 체내로 옮길 수 있습니다.

리포좀 보충제 시장은 신규 리포솜 기술 개발과 보충제 소비 증가 등의 요인으로 인해 미래에 유리한 성장이 예상됩니다.

시장 역학:

촉진요인과 억제요인

보충제 소비 증가

리포좀 보충제 시장은 영양 보충제 소비 증가에 의해 크게 견인될 것으로 예상됩니다. 소비자는 영양 보충재에 의한 건강 효과를 인식하게 되고, 대부분이 정기적인 섭취를 시작하고 있습니다. 지난 10년 동안 COVID-19의 대유행은 영양 보충제의 소비 증가의 주요 원동력 중 하나가 되었습니다. 이 기간 동안 사람들은 분명히 그 건강 효과를 실감하고 일부 인구 집단이 계속 섭취하고 있습니다. 예를 들어, 2023년 7월 MDPI Nutrients Journal에 게재된 논문에 따르면 COVID-19의 대유행 중 비타민 C 소비량은 40% 가까이 급증하고 멀티 비타민 소비량은 82% 증가했습니다.

리포솜 기술은 의약품의 약물전달로서 오래전부터 확립되어 왔지만, 영양 보조 식품에 대한 채용은 최근 증가하고 있습니다. 이 첨단기술을 이용한 비타민, 미네랄, 기타 영양보조식품의 제제화는 제조업체 각사에서 채용이 진행되고 있습니다. 게다가, 소비자는 리포좀 제형이 기존 것보다 우수하다는 것을 인식하고 있습니다. 이것은 예측 기간 동안 리포좀 보충제의 채용을 촉진할 것으로 예상됩니다.

리포좀형 비타민 미네랄에 대한 소비자의 인식이 제한적이면 시장 성장을 억제할 수 있습니다.

영양 보조 식품에 대한 소비자 기반은 높지만 고급 리포솜 기술을 이용한 비타민 미네랄의 채용률은 낮습니다. 이는 건강상의 이점에 대한 인식이 낮고 비용이 높기 때문입니다. 특히 농촌에 사는 특정 인구 그룹에서는 이러한 영양보조식품을 입수할 기회가 적고 그 존재를 깨닫지 못할 가능성이 높습니다.

목차

제1장 조사 방법과 조사 범위

제2장 정의와 개요

제3장 주요 요약

제4장 시장 역학

• 영향요인
  • 성장 촉진요인
    • 보충제의 소비 증가
    • 첨단 리포솜 기술 개발 개발
  • 억제요인
    • 소비자의 인지도의 낮음
  • 기회
  • 영향 분석

제5장 산업 분석

• Porter's Five Forces 분석
• 가격 분석
• 파이프라인 분석
• 특허 분석
• 규제 분석

제6장 제품 유형별

• 비타민
  • 비타민 A
  • 비타민 B
  • 비타민 C
  • 비타민 D
  • 비타민 E
  • 비타민 K
• 미네랄
  • 철
  • 아연
  • 마그네슘
  • 구리
  • 기타
• 아미노산 및 단백질
• 필수지방산
• 프로바이오틱스 및 프리바이오틱스
• 기타

제7장 제형별

• 캡슐
• 태블릿
• 구미
• 사쉐
• 기타

제8장 지역별

• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 독일
  • 영국
  • 프랑스
  • 스페인
  • 이탈리아
  • 기타 유럽
• 남미
  • 브라질
  • 아르헨티나
  • 기타 남미
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • 한국
  • 기타 아시아태평양
• 중동 및 아프리카

제9장 경쟁 구도

• 경쟁 시나리오
• 시황·점유율 분석
• M&A 분석

제10장 기업 프로파일

• liposovit.com
  • 기업 개요
  • 제품 포트폴리오
    • 제품 설명
    • 제품의 주요 실적 평가 지표(KPI)
    • 과거 및 예측의 제품 판매
    • 제품 판매량
  • 재무 개요
    • 회사 수익
    • 지역별 수익분배
    • 수익 예측
  • 주요 발전
    • 합병과 인수
    • 주요 제품 개발 활동
    • 규제 당국의 승인 등
  • SWOT 분석
• LipoCellTech
• Liposoma BV
• Solaray
• NOW(R) Foods
• Rho Nutrition
• LivOn Labs
• YourZooki
• Pure Encapsulations
• Quicksilver Scientific, Inc.
• Valimenta
• Henry Blooms.
• AFT Pharmaceuticals.
• Lipolife
• 각 시장 진출기업에 대해서도 유사한 데이터가 제공됩니다.

제11장 부록

영문목차

The global Liposomal supplements market reached US$ 903.47 million in 2024 and is expected to reach US$ 1,568.00 billion by 2033, growing at a CAGR of 6.3% during the forecast period 2025-2033.

Liposomes are small vesicles made up of phospholipid bilayer and are widely used in pharmaceutical applications for drug delivery. Several supplements can be encapsulated in liposomes to enhance their stability, protect them from the gastrointestinal environment, and improve their overall absorption.

The liposomes which resemble the natural cell membrane enable supplements to enter the bloodstream directly, and then into cells ensuring higher bioavailability, as compared to traditional formulations. Almost all the fat-soluble vitamins, water-soluble vitamins, and minerals can be delivered into the body using liposomal carriers.

The market for liposomal supplements is expected to see lucrative growth in the future driven by factors such as the rising development of novel liposome technologies and the rising consumption of supplements

Market Dynamics: Drivers & Restraints

The rising consumption of supplements

The market for liposomal supplements is expected to be significantly driven by the rising consumption of dietary supplements. Consumers are becoming more aware of the health benefits caused by these dietary supplements and many of them have started the regular consumption practice. In this decade, Covid-19 pandemic is one of the major driver for the increased consumption of dietary supplements. During this period, people have evidently seen their health benefits, and several population groups have continued taking them. For instance, As per the article published in July 2023, in MDPI Nutrients Journal, during Covid-19 pandemic, nearly as surge of 40% in vitamin C consumption, 82% increase in multivitamin consumption was obsereved.

The liposomal technology, although long established for pharmaceutical drug delivery, its adoption for dietary supplements is growing in recent times. Formulation of vitamins, minerals, and other dietary supplements using this advanced technology is a practice that is being increasingly adopted by manufacturers. Moreover, consumers are becoming more aware of the advantages offered by liposomal forms over traditional ones. This is anticipated to drive the adoption of liposomal supplements in the forecast period.

Limited consumer awareness of liposomal vitamins and minerals may restrain the market growth.

Although the consumer base for dietary supplements is high, the adoption rate of vitamins and minerals made using advanced liposomal technology is lower. This is due to a lack of awareness regarding the health benefits, and also the higher cost. This is especially high in certain population groups living in rural areas who may have less access to these dietary supplements and may be unaware of their existence.

Segment Analysis

The global liposomal supplements market is segmented based on Product Type, Dosage Form, and region.

Vitamins in the product type segment have the highest market share in the U.S. liposomal vitamins and minerals market.

Vitamins are the most commonly used dietary supplements in across the globe. All the vitamins are essential micronutrients, and they play a crucial role in maintaining overall health and well-being. The human body cannot produce the majority of the vitamins, and to maintain proper functioning, they must be obtained from external sources like diet and supplementation.

Dietary supplements are consumed by all types of populations to promote their health and well-being. Among these vitamins are the most widely consumed dietary supplements. For instance, a survey published in the Journal of American Heart Association, in May 2024 stated that among the population with atherosclerotic cardiovascular disease, the vitamin intake is higher. 35.4% of the survey population reported regular consumption of multivitamins, and 30.8% reported regular consumption of Vitamin D. This represents the demand for vitamins among patients suffering from chronic diseases.

Geographical Analysis

North America is expected to hold a significant share and grow with a highest CAGR in the forecast period.

North America region is well known for its advanced healthcare and wellness industry. The population in the U.S. are highly aware of the health benefits of dietary supplements and the consumer base for these products is huge. For instance, as per the Council for Responsible Nutrition (CRN) 2023 Survey data, 74% of U.S. adults consume dietary supplements and 55% of adults consume them regularly.

Additionally, North America, especially U.S. holds significant proportion of market players who are innovating novel liposomal technologies and are launching advanced formulations. For instance, In May 2024, Vida Lifescience announced the launch of new nano-liposomal products notably Nano-Liposomal Vitamin C (3000mg) Drink Mix and Nano-Liposomal Glutathione (750mg) Drink Mix in the U.S. market. These are the proprietary brands of Aurora Nutrascience, and Vida has the exclusive rights to distribute its products in the U.S. market. In January 2025, Renue by Science has launched a new range of supplements for skin health under the brand name Renue Blue. These products are made with cutting-edge ingredients and nanoliposome technology.

The huge consumer base for supplements in the U.S. coupled with advanced product launches drives the adoption of liposomal supplements in the region.

Competitive Landscape

The major global players in the Liposomal supplements market are liposovit.com, LipoCellTech, Liposoma BV, Solaray, NOW(R) Foods, Rho Nutrition, LivOn Labs, YourZooki, Pure Encapsulations, Quicksilver Scientific, Inc., Valimenta, Henry Blooms., AFT Pharmaceuticals. and Lipolife among others.

Key Developments

• In January 2025, Jiva Technologies has launched new website www.LIV3Health.com, for LIV3 Health, which marks the commencement of LIV3's flagship SugarShield supplement presale orders. The platform serves as an early gateway for health-conscious consumers to secure the LIV3's supplements. The shipments to customers are expected to begin in Q1 of 2025.
• In July 2024, Immod announced the launch of new line of supplements called Cell Boost & Balance - CellBB. These advanced supplements are made of patented blend of liposomal phospholipids which are aimed at boosting cellular health, and support immunity.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming pharmaceutical advancements.
• Product Type Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient Product Type delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global Liposomal supplements market report would provide approximately 66 tables, 51 figures, and 165 pages.

Target Audience 2023

• Manufacturers: Pharmaceutical, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Dosage Form
• 3.3. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Rising Consumption of Supplements
    • 4.1.1.2. Rising Development of Advanced Liposomal Technologies
  • 4.1.2. Restraints
    • 4.1.2.1. Limited Consumer Awareness
  • 4.1.3. Opportunities
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Pricing Analysis
• 5.3. Pipeline Analysis
• 5.4. Patent Analysis
• 5.5. Regulatory Analysis

6. By Product Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 6.1.2. Market Attractiveness Index, By Product Type
• 6.2. Vitamins*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.2.3. Vitamin A
  • 6.2.4. Vitamin B
  • 6.2.5. Vitamin C
  • 6.2.6. Vitamin D
  • 6.2.7. Vitamin E
  • 6.2.8. Vitamin K
• 6.3. Minerals
  • 6.3.1. Iron
  • 6.3.2. Zinc
  • 6.3.3. Magnesium
  • 6.3.4. Copper
  • 6.3.5. Others
• 6.4. Amino Acids & Proteins
• 6.5. Essential Fatty Acids
• 6.6. Probiotics & Prebiotics
• 6.7. Others

7. By Dosage Form

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage Form
  • 7.1.2. Market Attractiveness Index, By Dosage Form
• 7.2. Capsules*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Tablets
• 7.4. Gummies
• 7.5. Sachets
• 7.6. Others

8. By Region

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 8.1.2. Market Attractiveness Index, By Region
• 8.2. North America
  • 8.2.1. Introduction
  • 8.2.2. Key Region-Specific Dynamics
  • 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage Form
  • 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 8.2.5.1. U.S.
    • 8.2.5.2. Canada
    • 8.2.5.3. Mexico
• 8.3. Europe
  • 8.3.1. Introduction
  • 8.3.2. Key Region-Specific Dynamics
  • 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage Form
  • 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 8.3.5.1. Germany
    • 8.3.5.2. U.K.
    • 8.3.5.3. France
    • 8.3.5.4. Spain
    • 8.3.5.5. Italy
    • 8.3.5.6. Rest of Europe
• 8.4. South America
  • 8.4.1. Introduction
  • 8.4.2. Key Region-Specific Dynamics
  • 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage Form
  • 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 8.4.5.1. Brazil
    • 8.4.5.2. Argentina
    • 8.4.5.3. Rest of South America
• 8.5. Asia-Pacific
  • 8.5.1. Introduction
  • 8.5.2. Key Region-Specific Dynamics
  • 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage Form
  • 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 8.5.5.1. China
    • 8.5.5.2. India
    • 8.5.5.3. Japan
    • 8.5.5.4. South Korea
    • 8.5.5.5. Rest of Asia-Pacific
• 8.6. Middle East and Africa
  • 8.6.1. Introduction
  • 8.6.2. Key Region-Specific Dynamics
  • 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage Form

9. Competitive Landscape

• 9.1. Competitive Scenario
• 9.2. Market Positioning/Share Analysis
• 9.3. Mergers and Acquisitions Analysis

10. Company Profiles

Key Market Players

• 10.1. liposovit.com*
  • 10.1.1. Company Overview
  • 10.1.2. Product Portfolio
    • 10.1.2.1. Product Description
    • 10.1.2.2. Product Key Performance Indicators (KPIs)
    • 10.1.2.3. Historic and Forecasted Product Sales
    • 10.1.2.4. Product Sales Volume
  • 10.1.3. Financial Overview
    • 10.1.3.1. Company Revenue's
    • 10.1.3.2. Geographical Revenue Shares
    • 10.1.3.3. Revenue Forecasts
  • 10.1.4. Key Developments
    • 10.1.4.1. Mergers & Acquisitions
    • 10.1.4.2. Key Product Development Activities
    • 10.1.4.3. Regulatory Approvals etc.
  • 10.1.5. SWOT Analysis
• 10.2. LipoCellTech
• 10.3. Liposoma BV
• 10.4. Solaray
• 10.5. NOW(R) Foods
• 10.6. Rho Nutrition
• 10.7. LivOn Labs
• 10.8. YourZooki
• 10.9. Pure Encapsulations
• 10.10. Quicksilver Scientific, Inc.
• 10.11. Valimenta
• 10.12. Henry Blooms.
• 10.13. AFT Pharmaceuticals.
• 10.14. Lipolife
• Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

11. Appendix

• 11.1. About Us and Services
• 11.2. Contact Us